久久精品99久久香蕉欧美,92欧美成人午夜福利免费视频,一区二区三区日本伦理

国产精品毛片乱子乱人仑-久久欢久久精品久久久-极品少妇被猛得直流白浆-骚浪大鸡巴怒插进去嫩逼专辑视频

About US

About US

Introduction

Our Value

History

Contact Us

Join Us
Patients

Patients

Patients

Peripheral Arterial Disease

Peripheral Arteriosclerosis

Peripheral Venous Disease

Varicosity

Peripheral Arterial Disease

Peripheral Venous Disease

Peripheral Arteriosclerosis

Varicosity
Professional Medical Solutions

Professional Medical Solutions

Products

Peripheral Artery

PTA Catheter

ATK DCB Dilatation catheter

BTK DCB Dilatation Catheter

Support Catheter

Peripheral Cone-shaped Balloon Dilation Catheter

Peripherally Detachable Mechanical Fibered Coil

Microguidewire

Peripheral High-Pressure Balloon Dilatation Catheter

Peripheral Vein

Peripheral Vascular Aspiration System

Endovenous RF Closure System

Second Generation Peripheral Vascular Aspiration S

Support Catheter for Thrombus Aspiration Catheters

Embolectomy Device For Peripheral Thrombus Aspiration Catheter

Pressure Control Connection Tube

Maintenance Of Arteriovenous Fistula Access

DCB Dilatation Catheter for Hemodialysis Access

Peripheral Scoring Balloon Dilatation Catheter

Neurovascular

Endocranial Balloon Dilatation Catheter

Vertebral Artery Paclitaxel-Coated Balloon Dilation Catheter

Coronary Artery

Coronary Artery Balloon Dilatation Catheter

RT-Zero Coronary Artery Balloon Dilatation Cathete

Vericor-14 Microtubule

Coronary High-pressure Balloon

Coronary CTO Retrograde Micro-Catheter

Cardiac Valve Balloon Dilatation Catheter

Paclitaxel releases coronary balloon dilating cath

Coronary Sirolimus DCB

Academic

Peripheral Artery

Peripheral Vein

Maintenance Of Arteriovenous Fistula Access

Neurovascular

Coronary Artery

PTA Catheter

ATK DCB Dilatation catheter

BTK DCB Dilatation Catheter

Support Catheter

Peripheral Cone-shaped Balloon Dilation Catheter

Peripherally Detachable Mechanical Fibered Coil

Microguidewire

Peripheral High-Pressure Balloon Dilatation Catheter

Peripheral Vascular Aspiration System

Endovenous RF Closure System

Second Generation Peripheral Vascular Aspiration S

Support Catheter for Thrombus Aspiration Catheters

Embolectomy Device For Peripheral Thrombus Aspiration Catheter

Pressure Control Connection Tube

DCB Dilatation Catheter for Hemodialysis Access

Peripheral Scoring Balloon Dilatation Catheter

Endocranial Balloon Dilatation Catheter

Vertebral Artery Paclitaxel-Coated Balloon Dilation Catheter

Coronary Artery Balloon Dilatation Catheter

RT-Zero Coronary Artery Balloon Dilatation Cathete

Vericor-14 Microtubule

Coronary High-pressure Balloon

Coronary CTO Retrograde Micro-Catheter

Cardiac Valve Balloon Dilatation Catheter

Paclitaxel releases coronary balloon dilating cath

Coronary Sirolimus DCB
News

News

Corporate News

R&D Progress
Investor Relations

国产精品毛片乱子乱人仑-久久欢久久精品久久久-极品少妇被猛得直流白浆-骚浪大鸡巴怒插进去嫩逼专辑视频

About US

Patients

Professional Medical Solutions

News

News

Latest Info

Acotec reports 2023 annual results: full-year revenue of $474 million, up 20% year-over-year, as second growth curve matures

Acotec Holdings, LLC and Boston Scientific Corporation Announce Partial Offer and Collaboration Between Them

Notice on the Public Announcement of 2025 National Science and Technology Award Submissions

Acotec reports 2023 annual results: full-year revenue of $474 million, up 20% year-over-year, as second growth curve matures

Acotec and Boston Scientific Sign Master Collaboration Agreement and Master Service Agreement

Acotec and Boston Scientific Sign Memorandum of Understanding

先瑞達(dá)AcoStream?二代獲NMPA批準(zhǔn)上市

Acotec Reports 2022 Annual Results: full-year revenue of $396 million, up 30% year-over-year

Acotec Holdings, LLC and Boston Scientific Corporation Announce Partial Offer and Collaboration Between Them

先瑞達(dá)NEO-Skater顱內(nèi)球囊擴(kuò)張導(dǎo)管獲批上市

先瑞達(dá)外周一次性使用支撐導(dǎo)管（Vericor）獲美國(guó)FDA批準(zhǔn)注冊(cè)

先瑞達(dá)2022中期業(yè)績(jī)發(fā)布：營(yíng)收1.75億元，同比增長(zhǎng)25%，增長(zhǎng)點(diǎn)多元化

先瑞達(dá)外周一次性使用支撐導(dǎo)管（Vericor）獲批上市

先瑞達(dá)AcoArt Orchid?&Dhalia? DCB用于血液透析患者自體動(dòng)靜脈瘺狹窄（AVF）PTA術(shù)適應(yīng)癥的拓展獲批

先瑞達(dá)射頻消融全套設(shè)備獲批上市靜脈領(lǐng)域布局再獲突破

先瑞達(dá)發(fā)布2021年業(yè)績(jī)報(bào)告：全年?duì)I收3.04億元，同比增長(zhǎng)56.6%，調(diào)整后凈利潤(rùn)同比增長(zhǎng)140.4%

道阻且長(zhǎng) 行則將至 | 先瑞達(dá)2021年終盤點(diǎn)

先瑞達(dá)向美國(guó)FDA遞交ACOART LITOS?紫杉醇涂層經(jīng)皮腔內(nèi)血管成形術(shù)(PTA)球囊導(dǎo)管的IDE申請(qǐng)

先瑞達(dá)披露2021年年度經(jīng)營(yíng)數(shù)據(jù)預(yù)測(cè)：年度營(yíng)收和毛利較去年同比實(shí)現(xiàn)大幅增長(zhǎng)

中國(guó)藥監(jiān)局受理先瑞達(dá)動(dòng)靜脈導(dǎo)入DCB產(chǎn)品上市許可申請(qǐng)

先瑞達(dá)榮膺格隆匯“年度最具創(chuàng)新力IPO”獎(jiǎng)

先瑞達(dá)抽吸導(dǎo)管獲批上市外周介入先發(fā)優(yōu)勢(shì)快速擴(kuò)張

国产精品毛片乱子乱人仑-久久欢久久精品久久久-极品少妇被猛得直流白浆-骚浪大鸡巴怒插进去嫩逼专辑视频

About US

Patients

Professional Medical Solutions

News

News

Latest Info

Acotec reports 2023 annual results: full-year revenue of $474 million, up 20% year-over-year, as second growth curve matures

Acotec Holdings, LLC and Boston Scientific Corporation Announce Partial Offer and Collaboration Between Them

Notice on the Public Announcement of 2025 National Science and Technology Award Submissions

Acotec reports 2023 annual results: full-year revenue of $474 million, up 20% year-over-year, as second growth curve matures

Acotec and Boston Scientific Sign Master Collaboration Agreement and Master Service Agreement

Acotec and Boston Scientific Sign Memorandum of Understanding

先瑞達(dá)AcoStream?二代獲NMPA批準(zhǔn)上市

Acotec Reports 2022 Annual Results: full-year revenue of $396 million, up 30% year-over-year

Acotec Holdings, LLC and Boston Scientific Corporation Announce Partial Offer and Collaboration Between Them

先瑞達(dá)NEO-Skater顱內(nèi)球囊擴(kuò)張導(dǎo)管獲批上市

先瑞達(dá)外周一次性使用支撐導(dǎo)管（Vericor）獲美國(guó)FDA批準(zhǔn)注冊(cè)

先瑞達(dá)2022中期業(yè)績(jī)發(fā)布：營(yíng)收1.75億元，同比增長(zhǎng)25%，增長(zhǎng)點(diǎn)多元化

先瑞達(dá)外周一次性使用支撐導(dǎo)管（Vericor）獲批上市

先瑞達(dá)AcoArt Orchid?&Dhalia? DCB用于血液透析患者自體動(dòng)靜脈瘺狹窄（AVF）PTA術(shù)適應(yīng)癥的拓展獲批

先瑞達(dá)射頻消融全套設(shè)備獲批上市 靜脈領(lǐng)域布局再獲突破

先瑞達(dá)發(fā)布2021年業(yè)績(jī)報(bào)告：全年?duì)I收3.04億元，同比增長(zhǎng)56.6%，調(diào)整后凈利潤(rùn)同比增長(zhǎng)140.4%

道阻且長(zhǎng) 行則將至 | 先瑞達(dá)2021年終盤點(diǎn)

先瑞達(dá)向美國(guó)FDA遞交ACOART LITOS?紫杉醇涂層經(jīng)皮腔內(nèi)血管成形術(shù)(PTA)球囊導(dǎo)管的IDE申請(qǐng)

先瑞達(dá)披露2021年年度經(jīng)營(yíng)數(shù)據(jù)預(yù)測(cè)：年度營(yíng)收和毛利較去年同比實(shí)現(xiàn)大幅增長(zhǎng)

中國(guó)藥監(jiān)局受理先瑞達(dá)動(dòng)靜脈導(dǎo)入DCB產(chǎn)品上市許可申請(qǐng)

先瑞達(dá)榮膺格隆匯“年度最具創(chuàng)新力IPO”獎(jiǎng)

先瑞達(dá)抽吸導(dǎo)管獲批上市 外周介入先發(fā)優(yōu)勢(shì)快速擴(kuò)張

先瑞達(dá)2022中期業(yè)績(jī)發(fā)布：營(yíng)收1.75億元，同比增長(zhǎng)25%，增長(zhǎng)點(diǎn)多元化

先瑞達(dá)射頻消融全套設(shè)備獲批上市靜脈領(lǐng)域布局再獲突破

先瑞達(dá)發(fā)布2021年業(yè)績(jī)報(bào)告：全年?duì)I收3.04億元，同比增長(zhǎng)56.6%，調(diào)整后凈利潤(rùn)同比增長(zhǎng)140.4%

先瑞達(dá)抽吸導(dǎo)管獲批上市外周介入先發(fā)優(yōu)勢(shì)快速擴(kuò)張